As research progresses in the field of vaccinology, momentum has been gained to develop an efficacious and efficient dengue virus (DV) vaccine for all four serotypes. Dengue viral outbreaks across the world have called for a vaccine campaign. However, due to anti--"body dependent enhancement of infection, dengue virus has provided Researchers with challenges in developing a safe vaccine. Currently, there are a handful of vaccine candidates in clinical trial, but live chimeric attenuated vaccines dominate them.
Download count: 0